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Abstract
High-fructose com syrup has been used with increasing commonality in recent
decades. During this interval there is strong evidence o f increased occurrence o f
autoimmune disease. We hypothesized that increased glucose and fructose concentration
activates T-cells. Using Jurkat T-cells as a model, we found that increased glucose and
fructose concentration decreased Jurkat T-cell proliferation and death rates at pH 7.4
while at pH 7.2 the above effects did not reach significance. Cells in high glucose and
fructose concentration formed clusters that were unbreakable by standard trituration
techniques suggesting the expression o f high-affinity adhesion molecules characteristic o f
T-cell activation; this effect was more prominent in fructose than glucose formulations.
We conclude that exposure o f activated T-cells to sustained higher sugar concentration
may contribute to the development o f autoimmune disease.

This thesis continues to

discuss suggested future directions o f this research, its applications, and implications in
the pathophysiology o f autoimmune disease.
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C. Thesis Text
a.
Introduction
Hyperglycemia
A higher than norm al glucose concentration in plasm a is common in certain
physiological and pathophysiological states. Glucose concentration is elevated
during such conditions as uncontrolled diabetes[2], sym pathoexitation[l],
system ic inflam m ation[2] and transiently elevated after consum ption of food w ith
high sugar contents[3]. All above-m entioned conditions are show n to be associated
w ith eith er ÏH-cell activation or inflam m ation w h ere ÏH-cells are firmly know n to be
activated.
Fructose and inflam m ation
Consumption of food w ith high fructose contents results in a higher th an
norm al total glucose and fructose, h ereafter referred to as sim ple sugars,
concentration in plasm a[3]. Fructose has been show n to induce the expression of
the inflam m atory and adhesion molecule ICAM-1 in endothelial cells [4]. High
glucose has also been show n to induce endothelial inflam m ation[5]. As such,
inflamed endothelium is the m ost likely place w h ere activated T-cells are a rre sted
w ith hom otypic high-affinity adhesion molecules and sta rt extravasation.
Direct effects of glucose and fructose on T-cell activity
It is known that glucose tra n sp o rte r molecules GLUT1 and GLUT3 are
expressed in resting lymphocytes, th a t lymphocytes do not express GLUT2 or
GLUT4, and th at GLUT5 mRNA b ut not protein has been detected in resting
lym phocytes[6]. There is not, how ever, clear data available on GLUT family
tra n sp o rte r expression in various stages of lymphocyte activation. Though th e re are
9

num erous studies and review s which d em onstrate contribution of elevated

concentration of simple sugars, especially glucose and fructose, to TH-cell
activation and inflammation on the systemic and organ levels, there are no
studies on how higher concentrations of glucose and fructose affect TH-cell
activity at a cellular level.
H ypotheses
We hypothesize th a t (1) a higher glucose concentration decreases
Jurkat T-Lymphocyte (JTL) proliferation rate and th a t (2) fructose does not
affect JTL proliferation. We also hypothesize th a t (3) a higher glucose
concentration decreases JTL death rate and th a t (4) fructose does n o t affect
JTL death. Using 5.6 mM glucose as a control, here we re p o rt th e effects of
11.2mM glucose (double norm al) and 5.6mM glucose + 5.6mM fructose on
the activity of Jurkat T-cells (JTL).
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b.

Methods and Materials

Cell Culture
Jurkat T-cells (E6-1 line) stored in liquid nitrogen w ere rapidly th aw ed and
resuspended in Advanced RPMI-1640 supplem ented w ith 10% heat-inactivated
fetal bovine serum and 2 mM Glutamax in small culture flasks. Flasks for pH 7.4
form ulations w ere incubated a t 37°C w ith 9 5 % air/5 % CO2. Those for pH7.2
form ulations w ere incubated 9 0% air/1 0 % CO2 w ith all o th er p aram eters being
identical, thereby creating an acidic environm ent w ithout th e use of buffers or o th er
chemical additives. Cultures w ere split and fresh m edia added to m aintain th e
density of viable cells a t approxim ately 105 cells/m L as needed. The absence of
m edia contam ination w as visually using light microscopy; biochem ical assays for
m ycoplasm al contam ination w ere not perform ed. Experim ental cultures w ere
placed in a 12-well plate w ith 4 wells for each control (5.6 mM glucose and 5.6 mM
glucose + 5.6 mM fructose), and each treatm en t group (11.2 mM glucose and 5.6
fructose). Form ulations containing 5.6 mM glucose, and 5.6 mM glucose + 5.6 mM
fructose w ere used as controls because neither Glut-5 expression nor fructose
uptake by JTL has been dem onstrated.
Trypan Blue Assay
Cell viability w as assessed by inspection of cells using light m icroscopy and
trypan blue assay. For this, cells 50pL of tritu ra ted cell suspension w as com bined
w ith 50pL of m icrofiltered trypan blue and m ounted on a stan d ard hem ocytom eter.
Counts of live and dead cells for all sam ples w ere obtained by th e sam e technician as
well as counts of clusters of 3 ,4 and 5 or more. Clusters of 2 w ere counted for total
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cell count b u t not for cluster count as they are visually indiscernible from
m itotically diving cells. Manual counting w as em ployed in anticipation of
autom ated counter e rro r due to cluster form ation. M icrograph im ages w ere
obtained using a Nikon Eclipse E200 m icroscope w ith a Nikon DN100 digital
cam era. All images w ere retained for fu rth er analyses including cell
diam eter distribution and possible recounts (Figure 4a-f).
Form ulae
Proliferation rate (PR) and death rate (DR) w ere determ ined by the
form ulae below such th a t live cell counts a t 0 hours (AO) and a t 48 hours
(A48) and such th a t dead cell counts a t 0 hours (DO) and 48 hours (D48).

Statistical Analysis
Data w ere evaluated for significance using a tw o-tailed Student's Tte st w ith significance threshold p<0.05. T reatm ent interaction effects w ere
determ ined by the tw o-w ay ANOVA (factorial) m ethod using Statistical
Analysis System (SAS) version 9.3.
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c.
Proliferation Rate

Results

We observed a significant decrease in proliferation rate of glucose tre a ted
cells a t pH 7.4 com pared to control (p < 0.05). The decrease in proliferation of
fructose treated cells did not reach significance (p = 0.135). T here w as no significant
differences in the respective proliferation of both glucose and fructose tre a tm e n ts at
pH 7.2 (Figure 1).

Death Rate
We next investigated the respective effects of glucose and fructose on cell
death. A significant decrease in death rate a t pH 7.4 of both glucose (p < 0.05) and
fructose (p < 0.05) w hen com pared to 7.4 control w as observed. A sim ilar decrease
in cell death was observed at 7.2 but it did not reach a significant level. Although
death decreased at pH 7.2 com pared to pH 7.4, it w as n o t significant (p=0.114)
(Figure 2).

Clusterization as a measurement of physiological CAM activation
Clusters of three or m ore cells w ere counted, excluding clusters of tw o which
are difficult to visually discern from mitotically active cells. Cluster counts of three,
four and five or m ore cells w ere compiled for graphing and statistical analysis by the
original formula below:

Total clustered cells = (3 )( Clusters o f 3) + (4)(Clusters o f 4) 4- ( 5)(Clusters o f 5)

Significant increases in the num ber of clusterized cells a t pH 7.4 w as observed in
fructose (p < 0.001) and glucose (p<0.005) w hen com pared to control, and the
difference betw een glucose and fructose was not significant (p=0.260). Similar to pH
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7.4, a t pH 7.2 the num ber of clusterized cells in both glucose (p < 0.05) and
fructose (p < 0.001) w as significantly different from control; how ever, a t this
pH the difference betw een glucose and fructose w as significant (p<0.005).
Furtherm ore, w hen com paring w ithin sugar tre a tm e n t groups, glucose
tre a tm e n t form ed significantly m ore clusterized cells a t pH 7.4 than 7.2 (p <
0.01) while in fructose tre a tm e n t this difference w as n o t significant (p =
0.106)
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d. Discussion
In this study w e hypothesized th a t p ro tracted increases in sugar
concentration contribute to activation of T-cells and provide evidence to su p p o rt
this hypothesis in vitro using Jurkat T-cells. To our know ledge this is the first
evidence of direct activation of T-cells by com m only used sugars, glucose and
fructose.

The role of simple sugars in T-cell activation
After activation by an antigen-presenting cell, T-cells undergo a period of
clonal expansion in the secondary lymph nodes p rio r to entering th e circulation
w here they can encounter elevated glucose and fructose concentrations sim ilar to
those exam ined in the p resen t study. T-cells move freely through th e circulation
until they come in contact w ith chem okines released from inflam ed endothelium
which activate already expressed, b u t inactive, high affinity adhesion m olecules on
T-cell m em branes.
W hat does a decrease in Proliferation rate m ean for T-cell activation?
We observed th a t increased sugar concentration results in decreased cell
proliferation rate w ithin 48 hours. This effect su p p o rts our hypothesis th a t
increased glucose decreases T-cell proliferation in glucose form ulations. A decrease
in proliferation was also seen in fructose form ulations, possibly suggesting th a t
activated T-cells m ust up-regulate GLUT5 and are capable of utilizing fructose,
contrary to previously published results. A sim ilar suppression of proliferation in
association w ith increased glucose concentration has been rep o rted in
fibroblasts[7] and endothelial cells[8] w here the effect w as reversible by
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antioxidant tre a tm e n t im plicating free radicals in th e m echanism of this
observation. W ith regard to T-cells, w e reason th a t th e observed effect on
proliferation may result in lym phopenia in instances of chronic elevation of
serum sugar levels. Thereby, our data offer potential evidence th a t supports
a possible developm ental m echanism of lym phopenia, which has been
recently review ed and described as elusive[9]. Lym phopenia drives
hom eostatic proliferation of T-cells w hich results in an increased population
of m em ory-like T-cells ra th e r than increasing th e naive cell pool [9]. These
conditions have been show n to lead to an increase T-cell activation[9].
W hat does a decrease in death ra te m ean for T-cell activation?
We observed th a t increased sugar concentration results in decreased
T-cell death rate. This effect w as also seen in both glucose and fructose
groups, again possibly suggesting th a t in states of activation lym phocytes
change th eir expression profiles of GLUT family tran sp o rters. Similar antiapoptotic effects have been reported in o th er cell types in association w ith
increased glucose m etabolism [10 ,ll,1 2 ]. One study proposes the
m echanism th a t glucose m etabolism inhibits apoptosis by redox inactivation
of cytochrom e c[12]. The above-m entioned role of free radicals and the here
referenced effect of redox signaling in chronic inflam m atory states have been
show n to affect T-cell function[13]. Our data are consistent w ith the
predictions of these rep o rts and may d em onstrate th a t elevated sugar
concentrations, resulting in hyperglycem ic-induced production of free
radicals and redox inactivation of cytochrom e c, can lead to T-cell activation.
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W hat does clusterization ra te m ean for T-cell activation?
W e observed th a t increased sugar concentration prom otes cellular adhesion
in T-cells w hich caused th e form ation of clusters. W hile intracellular adhesion
m olecule 1 (ICAM-1) is continuously p resen t in T-cell m em branes in low levels, the
cluster form ing effect seen h ere is possibly a p roduct of the up-regulating effect of
glucose m etabolism on ICAM-1 expression. This phenom enon has been rep o rted in
o th er cell types including endothelial cells[14,15] and has been show n to increase
leukocyte-endothelial cell adhesion[16].
Our data show th a t sugar m etabolism affects the functioning of cell adhesion
molecules. In vitro, this resulted in the form ation of T-cell clusters potentially by
hom otypic adhesion, in vivo this could resu lt in th e adhesion of T-cells to endothelial
cells and T-cell extravasation[16]. T here is som e evidence suggesting a novel model
of intracellular signaling w hich results from ICAM-1 cross linking in endothelial
cells[17]. In conjunction w ith this report, our data fu rth er d em onstrate how
increased sugar m etabolism can contribute to T-cell activation.

Relevance in Disease States
The findings of our study have potential relevance for a num ber of disease
states including chronic stress, diabetes, chronic inflam m ation and autoim m une
disease as well as various o th er conditions not discussed a t length herein.
Stress and sym pathoexcitation
The hypothalam ic-pituitary-adrenal (HPA) axis is excited in sym pathetic
response to psychological and physiological stress. Interaction of HPA organs
involved in the stress response begets the release of epinephrine and cortisol.
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Epinephrine acts on a- and p-adrenergic receptors which inhibit insulin
release, stim ulate glucagon release and stim ulate gluconeogenesis and
glycolysis. Cortisol has a sim ilar effect on glucose mobilization. These
conditions resu lt in increased serum glucose concentration. As described in
the previous subsection, our results may p resen t a potential m echanism by
w hich chronic stress can contribute to T-cell activation.
Furtherm ore, disease states associated w ith sym pathoexcitation
include chronic h e art failure[18], chronic obstructive pulm onary
disorder[19], coronary artery disease[20] and others which w e speculate can
also contribute to T-cell activation. Accordingly, p resen t study adds to the
ongoing discussion of these disorders as a p a rt of the constellation of
cardiovascular disorders th a t often occur w ith diabetes and are referred to
as the M etabolic Syndrome. Our data contribute som e causal evidence to the
largely undefined understanding of th e Metabolic Syndrome by delineating
the inter-relationships betw een sugar concentration and T-cell activation
and cardiovascular disease, diabetes, chronic inflammation and autoim m une
disease.
Diabetes and Chronic Inflamm ation
Diabetes is a chronic condition th a t is seen in association w ith by lowgrade system ic Inflamm ation[21] w hich is know n to prom ote the release of
chem okines by endothelial tissues. U ncontrolled diabetes rep resen ts a state
of long-term hyperglycem ia and is a close in vivo m anifestation of the
experim ental conditions w e have constructed. The findings of our study are
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therefore of particular significance in diabetes. Our d ata su p p o rt observations th a t
diabetes suppresses im m une statu s by identifying the anti-proliferatory effect of
hyperglycem ia and suggest th a t the physiologic effects of the diabetic condition
contribute to activation of T-cells long-term which in tu rn may lead to conditions
such as autoim m une disease. C onsistent w ith this, th ere is evidence th a t identifies
an increasing population of diabetic patients w ith com orbid autoim m une
diseases[22].
A utoim m une Disease
Our discussion of data has repeatedly enum erated our assertions th a t
chronic elevations in sugar concentration can lead to T-cell activation. This over
activity of the im m une system can lead to autoim m une disease. This effect is due in
large p a rt to the effects of hom eostatic proliferation and decreased T-cell death rate
as well as changes in T-cell adhesion molecule activity and increased release of
chem okines by inflamed endothelium . High-fructose corn syrup has been used w ith
increasing com m onality in recent d ecades[2 3]. During this interval th e re is stro n g
evidence of m arkedly increased occurrence of a m ultitude of autoim m une diseases
on a global scale[24,25,26,27,28,29,30]. Our data help to explain these tre n d s in
public health a t the cellular level.
Perspectives
Future directions of this young but compelling research should focus on
elucidating the m echanistic enigma of these rep o rted observations a t the m olecular
level. To this end, this research w ould benefit from further characterizing the
activity of T-cells under these experim ental conditions. This inform ation can be
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obtained through ELISA assays of cell suspension su p ern atan t for
interleukins, intracellular calcium studies using Fura2 and
im m unohistochem ical stains for m em brane proteins including adhesion
molecules. Genetic studies focusing on GLUT family expression should also
prove inform ative. Organismal studies will lend fu rth er u nderstanding to
the findings w e w itness a t the cellular level.
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Figure 4c: Micrograph of JTL cells, Fructose Oh
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